Abstract: A traveling control apparatus includes a speed control processor, first and second brake command detectors, a brake control processor, and an operational state setting unit. The speed control processor controls a vehicle speed to cause a vehicle to travel at a target speed, and is switchable between an active operational state and an inactive operational state. The first brake command detector detects a first brake command based on a driver's operation. The brake control processor generates a second brake command based on an environment outside the vehicle. The second brake command detector detects the second brake command. The operational state setting unit maintains the speed control processor in the active operational state when the first brake command is generated while the speed control processor is in the active operational state, and switches the speed control processor to the inactive operational state when the second brake command is generated.

Abstract: A quality improvement system using an FMEA table of the invention includes a defect data collecting unit to collect defect data about a defect in a manufacturing or inspection process and an FMEA table update unit to update the FMEA table online based on the data collected by the defect data collecting unit. The FMEA table includes a failure mode, the number of occurrences of the failure mode, and an effect caused by the failure mode. The FMEA table update unit includes an FMEA table editing unit to edit the FMEA table. The FMEA table editing unit edits the number of occurrences of the failure mode when a row including a set of an occurred failure mode and an effect corresponding to the occurred failure mode is previously defined in the FMEA table, and inserts the row into the FMEA table when the row is not defined in the FMEA table.

Abstract: A quality improvement system using an FMEA table of the invention includes a defect data collecting unit to collect defect data about a defect in a manufacturing or inspection process and an FMEA table update unit to update the FMEA table online based on the data collected by the defect data collecting unit. The FMEA table includes a failure mode, the number of occurrences of the failure mode, and an effect caused by the failure mode. The FMEA table update unit includes an FMEA table editing unit to edit the FMEA table. The FMEA table editing unit edits the number of occurrences of the failure mode when a row including a set of an occurred failure mode and an effect corresponding to the occurred failure mode is previously defined in the FMEA table, and inserts the row into the FMEA table when the row is not defined in the FMEA table.

Abstract: The invention is directed to an imidazole derivative represented by formula (1): wherein each of R1 and R2 represents an aryl group, a heteroaryl group, etc.; each of A, X1, and X2 represents N or CH; each of Y and Z represents O, S, etc.; each of R3, R4, and R5 represents a hydrogen atom, an alkyl group, etc.; m is a number of 1 to 4; and n is a number of 0 to 4, or a salt thereof. The invention is also directed to a drug containing the derivative or the salt as an active ingredient. These compounds exert excellent effects of inhibiting production of NO and IL-6 and are useful for preventing or treating diseases induced by overproduction of NO and IL-6.

Abstract: A method of providing a program for a printed board packaging line is disclosed. A board packaging line coordinating computer downloads the service contract information and the application program contained in the contract information from an application server, and defines the board packaging line covered by the program and the device configuration of the line. The device configuration thus defined is uploaded to the application server, which, based on the device configuration thus uploaded, searches a prepared device driver group for a required device driver. This device driver is downloaded and set in each device by the board packaging line coordinating computer.

Abstract: A method of providing a program for a printed board packaging line is disclosed. A board packaging line coordinating computer downloads the service contract information and the application program contained in the contract information from an application server, and defines the board packaging line covered by the program and the device configuration of the line. The device configuration thus defined is uploaded to the application server, which, based on the device configuration thus uploaded, searches a prepared device driver group for a required device driver. This device driver is downloaded and set in each device by the board packaging line coordinating computer.

Abstract: The invention is directed to an imidazole derivative represented by formula (1): 1

Abstract: A debugger program product is described which comprises a computer readable medium having computer program logic stored therein for debugging the operation of a target system which is provided with a microprocessor. The debugger program product including a framework module configured such that it can be dynamically linked to a function module which serves to provide a debug function for use in debugging the operation of the target system and can be connected to a simulator capable of performing the simulation of the target system in order to debug the operation of the target system by the use of the debug function of the function module.

Abstract: Disclosed are chromene derivatives represented by the following formula: ##STR1## wherein R.sup.1 s represent alkyl, alkoxy or like groups, R.sup.2 represents a hydrogen atom or an alkyl group, R.sup.3 represents a substituted or unsubstituted phenyl, naphthyl or heterocyclic group, and m stands for an integer of from 0 to 4, and their salts; and pharmaceuticals containing them as effective ingredients. The chromene derivatives and their salts show excellent AGE formation inhibitory action and are useful as preventives and therapeutics for diabetic complications.

Abstract: A benzoazine derivative represented by the following formula (1), ##STR1## wherein R.sup.1 represents an alkyl group, alkoxy group, halogen atom, halogenoalkyl group, amino group, hydroxy group, benzyloxy group which may have a substituent, cyano group, carbamoyl group, acyl group, nitro group, carboxy group, or sulfonamide group; R.sup.2 and R.sup.3 may be the same or different and each individually represents a hydrogen atom or an alkyl group, or R.sup.2 and R.sup.3 indicate in combination an alkylene group having 2-7 carbon atoms; R.sup.4 and R.sup.5 may be the same or different and each individually represents a hydrogen atom or an alkyl group; X denotes O, S, or N--R.sup.6 (wherein R.sup.6 represents a hydrogen atom, an alkyl group, or an aryl group or pyridyl group which may have a substituent); m is an integer from 0 to 4; and n is an integer from 1 to 3, or a salt of the benzoazine derivative.